RT Journal Article SR Electronic T1 ERK5 Is a Potential Therapeutic Target in ALK-Positive Neuroblastoma JF Cancer Discovery JO CANCER DISCOVERY FD American Association for Cancer Research SP 1363 OP 1363 DO 10.1158/2159-8290.CD-RW2014-229 VO 4 IS 12 YR 2014 UL http://cancerdiscovery.aacrjournals.org/content/4/12/1363.2.abstract AB ERK5 promotes ALK-induced transcription of MYCN and enhances neuroblastoma cell proliferation.